These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7698209)

  • 21. Pharmacological characterization of the N-methyl-D-aspartate (NMDA) receptor recognition site in porcine cerebral cortical membranes using [3H]-CGP 39653.
    Banks MD; Sandberg MP; Fowler CJ
    Comp Biochem Physiol A Physiol; 1995 May; 111(1):39-46. PubMed ID: 7735908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are high affinity partial agonists at the cloned rat kappa-opioid receptor.
    Soderstrom K; Choi H; Berman FW; Aldrich JV; Murray TF
    Eur J Pharmacol; 1997 Nov; 338(2):191-7. PubMed ID: 9456002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inorganic iron complexes derived from the nitric oxide donor nitroprusside: competitive N-methyl-D-aspartate receptor antagonists with nanomolar affinity.
    Neijt H; Koller M; Urwyler S
    Biochem Pharmacol; 2001 Feb; 61(3):343-9. PubMed ID: 11172739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynorphin displaces binding at the glycine site of the NMDA receptor in the rat striatum.
    Voorn P; van de Witte SV; Li Kw; Jonker AJ
    Neurosci Lett; 2007 Mar; 415(1):55-8. PubMed ID: 17234341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium.
    Sarsero D; Molenaar P; Kaumann AJ
    Br J Pharmacol; 1998 Feb; 123(3):371-80. PubMed ID: 9504376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
    Devlin T; Shoemaker WJ
    J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative studies on binding of 3 different ligands to the N-methyl-D-aspartate recognition domain in brain synaptic membranes treated with Triton X-100.
    Zuo P; Ogita K; Han D; Yoneda Y
    Brain Res; 1993 Apr; 609(1-2):253-61. PubMed ID: 8099522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Norbinaltorphimine protection against N-methyl-D-aspartic acid-induced convulsions and mortality.
    Shukla VK; Lemaire S
    Eur J Pharmacol; 1993 Feb; 231(2):293-6. PubMed ID: 7681005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-affinity interaction of (des-Tyrosyl)dynorphin A(2-17) with NMDA receptors.
    Tang Q; Gandhoke R; Burritt A; Hruby VJ; Porreca F; Lai J
    J Pharmacol Exp Ther; 1999 Nov; 291(2):760-5. PubMed ID: 10525097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [3H]CGP 61594, the first photoaffinity ligand for the glycine site of NMDA receptors.
    Benke D; Honer M; Heckendorn R; Pozza MF; Allgeier H; Angst C; Mohler H
    Neuropharmacology; 1999 Feb; 38(2):233-42. PubMed ID: 10218864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A possible role of glutathione as an endogenous agonist at the N-methyl-D-aspartate recognition domain in rat brain.
    Ogita K; Enomoto R; Nakahara F; Ishitsubo N; Yoneda Y
    J Neurochem; 1995 Mar; 64(3):1088-96. PubMed ID: 7861138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat.
    Chen L; Gu Y; Huang LY
    J Physiol; 1995 Feb; 482 ( Pt 3)(Pt 3):575-81. PubMed ID: 7537820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of [3H]3-((+-)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid ([3H]CPP) binding by ligands acting at the glycine and the polyamine sites of the rat brain NMDA receptor complex.
    Porter RH; Briggs RS; Roberts PJ
    Eur J Pharmacol; 1992 Sep; 227(1):83-8. PubMed ID: 1426025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-methyl-D-aspartate receptor binding in brains of rats at different ages.
    Shimada A; Mukhin A; Ingram DK; London ED
    Neurobiol Aging; 1997; 18(3):329-33. PubMed ID: 9263199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynorphin block of N-methyl-D-aspartate channels increases with the peptide length.
    Chen L; Huang LY
    J Pharmacol Exp Ther; 1998 Mar; 284(3):826-31. PubMed ID: 9495839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mechanism of action for the block of NMDA receptor channels by the opioid peptide dynorphin.
    Chen L; Gu Y; Huang LY
    J Neurosci; 1995 Jun; 15(6):4602-11. PubMed ID: 7540680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
    Foster AC; Wong EH
    Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
    Cao YJ; Bian JT; Bhargava HN
    Eur J Pharmacol; 1997 Sep; 335(2-3):161-6. PubMed ID: 9369369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.
    Benveniste M; Mayer ML
    Br J Pharmacol; 1991 Sep; 104(1):207-21. PubMed ID: 1686203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kappa-binding and degradation of [3H]dynorphin A (1-8) and [3H]dynorphin A (1-9) in suspensions of guinea pig brain membranes.
    Gillan MG; Robson LE; McKnight AT; Kosterlitz HW
    J Neurochem; 1985 Oct; 45(4):1034-42. PubMed ID: 2863329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.